Journal of cosmetic dermatology · 2020
Comparative clinical study of the efficacy of intralesional MMR vaccine vs intralesional vitamin D injection in treatment of warts.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shaldoum Dalia R, Hassan Ghada F R, El Maadawy Eman H, El-Maghraby Gamal M
Аннотация
BACKGROUND: Many therapeutic modalities were reported for the treatment of warts; however, no single treatment is completely effective.
OBJECTIVE: To evaluate the efficacy of intralesional injection of MMR vaccine vs vitamin D in treatment of warts.
PATIENTS AND METHODS: A total of 60 patients were included in the study divided into two groups. Group A received intralesional MMR vaccine into largest wart, and group B received intralesional vitamin D3 into each lesion with maximum of five warts treated in one session. A maximum of six sessions was done every 3 weeks in both groups. Follow-up was done for 6 months for any recurrence.
RESULTS: In group A: complete response in 80%, partial response in 6.67%, minimal response in 6.67%, and no response in 6.67% of patients. About 60% of patients with multiple warts showed complete clearance of distant untreated warts. In group B: complete response in 66.7%, partial response in 6.67%, minimal response in 20%, and no response in 6.67% of patients. There was no significant difference between both groups. No recurrence was observed in both groups in the follow-up period.
CONCLUSIONS: Immunotherapy by both intralesional MMR vaccine and vitamin D3 is simple, well-tolerated, effective, and cost-benefit modalities for the treatment of warts.
OBJECTIVE: To evaluate the efficacy of intralesional injection of MMR vaccine vs vitamin D in treatment of warts.
PATIENTS AND METHODS: A total of 60 patients were included in the study divided into two groups. Group A received intralesional MMR vaccine into largest wart, and group B received intralesional vitamin D3 into each lesion with maximum of five warts treated in one session. A maximum of six sessions was done every 3 weeks in both groups. Follow-up was done for 6 months for any recurrence.
RESULTS: In group A: complete response in 80%, partial response in 6.67%, minimal response in 6.67%, and no response in 6.67% of patients. About 60% of patients with multiple warts showed complete clearance of distant untreated warts. In group B: complete response in 66.7%, partial response in 6.67%, minimal response in 20%, and no response in 6.67% of patients. There was no significant difference between both groups. No recurrence was observed in both groups in the follow-up period.
CONCLUSIONS: Immunotherapy by both intralesional MMR vaccine and vitamin D3 is simple, well-tolerated, effective, and cost-benefit modalities for the treatment of warts.